Safety Profile of Intrathecal Morphine in Obese Parturients Undergoing Caesarean Delivery: A Retrospective Study

Pain after surgery is a universal human experience, but for a mother who has just undergone a caesarean section, the stakes are uniquely high. She is expected to recover quickly, often within hours, to care for her newborn. If the pain is too severe, this crucial early bonding is disrupted, and the mother may struggle to move, increasing her risk of blood clots. To manage this pain, doctors often use a technique called spinal anaesthesia, where medication is injected directly into the fluid surrounding the spinal cord. This numbs the lower body for the operation and provides relief afterward. A common addition to this injection is a tiny amount of morphine, a powerful painkiller, which helps extend the relief for many hours. However, there is a lingering worry among medical providers, especially when the mother is obese. Obesity changes how the body handles drugs and can make breathing more difficult, leading some doctors to fear that adding morphine might cause dangerous respiratory depression, where breathing slows to a dangerous level. Because of this fear, many obese mothers might be given less pain relief than they need, or none at all, simply because the risk feels too great.

A team of researchers in Malaysia set out to investigate whether this fear was justified. They looked back at the medical records of 400 obese women who had undergone caesarean sections at a large hospital over a five-year period. All of these women received a standard dose of 0.1 milligrams of intrathecal morphine mixed with other local anaesthetics. The researchers wanted to see if this specific dose caused breathing problems or other serious side effects in women with higher body weights, and whether it actually helped control their pain. They tracked the women for 24 hours after surgery, watching their breathing, blood pressure, and pain levels, and also checked on the health of the babies.

The results were reassuring. In this group of 400 women, not a single case of respiratory depression occurred. No woman experienced a dangerous slowing of her breathing or a drop in oxygen levels that required emergency intervention. The most common side effects were nausea and itching. About 30 percent of the women felt nauseous within the first hour after surgery, and roughly 22 percent experienced itching, which peaked around 12 hours later. These symptoms were manageable and did not pose a life-threatening risk. The researchers also found that the severity of these side effects did not increase with the degree of obesity. Whether a woman had a body mass index of 30 or over 40, the rate of nausea, vomiting, or itching remained similar across the groups. This suggests that the extra body fat did not make the morphine more dangerous or more likely to cause side effects.

The pain relief provided by the morphine was also effective. For the first four hours after surgery, the women reported almost no pain. By the 24-hour mark, pain levels had risen slightly but remained at a manageable level for most. This early window of comfort allowed the mothers to move around and interact with their babies without being hindered by severe pain. The babies were also safe; their health scores at birth and shortly after were excellent and showed no difference based on their mothers' weight or the morphine dose. The study concluded that a standard dose of 0.1 milligrams of intrathecal morphine is safe and effective for obese mothers undergoing caesarean delivery. It provides strong pain relief without causing breathing problems, challenging the idea that this group of patients must be denied this effective treatment due to their weight. The findings suggest that with standard monitoring, obese mothers can receive the same high-quality pain management as anyone else, ensuring a safer and more comfortable recovery for both mother and child.